CD34+ Cell Targeted Antibody-Conjugated Premade EGFP mRNA Lipid Nanoparticle
The CD34+ Cell Targeted Antibody-Conjugated Premade EGFP mRNA Lipid Nanoparticle represents a cutting-edge targeted delivery system designed for precise mRNA delivery to CD34+ T cells. This innovative formulation combines the specificity of anti-human CD34 antibody with the efficiency of lipid nanoparticle technology to achieve enhanced cellular targeting. The system features covalently conjugated CD34 antibodies on the surface of SM102-based lipid nanoparticles, loaded with fully modified EGFP mRNA containing N1-methyl-pseudouridine (m1Ψ) modifications for improved stability and reduced immunogenicity.
Key Features
Targeted Delivery: Surface-conjugated anti-human CD34 antibody mAb for specific targeting of CD34+ T cells
Enhanced mRNA Stability: EGFP mRNA with 100% U-base modification using N1-methyl-pseudouridine (m1Ψ)
Optimized Formulation: SM102-based ionizable lipid system for improved cellular uptake and endosomal escape
Covalent Conjugation: Antibody covalently linked to lipid molecules ensuring stable targeting functionality
Ready-to-Use: Premade formulation eliminates preparation time and ensures batch-to-batch consistency
Research-Grade Quality: Manufactured under controlled conditions for reliable experimental results
Applications
T Cell Research: Studying CD34+ T cell biology, activation, and function
Immunotherapy Development: Evaluating targeted delivery approaches for T cell-based therapies
Cell Tracking Studies: Real-time monitoring of T cell populations using EGFP expression
Proof-of-Concept Studies: Demonstrating targeted mRNA delivery efficiency to specific immune cell populations
Drug Development: Screening and optimization of T cell-targeted therapeutic approaches
Flow Cytometry Analysis: Quantitative assessment of targeting efficiency and expression levels
Product Specifications
Parameter | Specification |
---|---|
Payload | EGFP mRNA (m1Ψ) |
Conjugated Antibody | CD34 mAb |
Ionizable Lipid | SM102 |
Formulation Components | Ionizable lipid, DSPC, PEG-2000 DMG, Cholesterol |
Storage Buffer | 10% Sucrose in TBS |
Appearance | Clear and colorless |
Concentration | Batch specific (~0.1 mg/mL) |
Availability | On-demand |
Storage & Handling Instructions
Storage Temperature: Store at 4°C immediately upon receipt
Shipping: Product is shipped on ice packs to maintain cold chain integrity
Handling Precautions:
Avoid freeze-thaw cycles to maintain nanoparticle integrity
Handle gently to prevent aggregation
Use sterile technique when aliquoting or diluting
Protect from prolonged exposure to room temperature
Keep away from light to preserve mRNA stability
Stability: When stored properly at 4°C, the product maintains stability for 6 months from the date of manufacture. For optimal performance, use within the specified timeframe.
Custom Solutions
At PreciGenome, we understand that research requirements vary. We offer comprehensive customization options for this product:
Alternative Targeting Antibodies: Custom antibody conjugation for different cell surface markers
Payload Modifications: Alternative mRNA sequences, reporters, or therapeutic genes
Formulation Adjustments: Modified lipid compositions or concentrations
Scale Options: Various volume and concentration specifications
Buffer Systems: Alternative storage and working buffers
Bulk Manufacturing: Large-scale production for extensive studies
Our technical team works closely with researchers to develop tailored solutions that meet specific experimental needs and research objectives.
Important Notes
For Research Use Only. This product is not for human or veterinary use.
For technical support, custom formulations, or bulk orders, please contact us.
This product contains genetically modified materials and should be handled according to institutional biosafety guidelines
Performance may vary depending on cell type, experimental conditions, and handling procedures
Optimal transfection conditions should be determined empirically for each specific application
Product specifications are subject to batch-specific variations; refer to individual Certificate of Analysis
Users should validate targeting efficiency and expression levels in their specific experimental systems
CD34+ Cell Targeted Antibody-Conjugated Premade EGFP mRNA Lipid Nanoparticle
More Information
Custom LNP Service
Targeted Lipid Nanoparticle
Documents
Datasheet